IMM-6-415

N/A

Report date: 2024/03/16 20:00:47
NME

Base Information

Drug NameIMM-6-415
Drug Alias NameIMM-6-415
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase inhibitors
TargetsDual specificity mitogen-activated protein kinase kinase
Therapy Area/IndicationsSkin MelanomaSolid tumoursCarcinoma, Non-Small-Cell Lung +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmuneering Corp
China Registration ClassN/A

Develop Information

Active CompaniesImmuneering Corp
Inactive CompaniesN/A
Active IndicationsSkin MelanomaSolid tumoursCarcinoma, Non-Small-Cell Lung +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A